Solutions For...
Latest Insights
The Benefits of Rapid Diagnostics at the Point of Care
Throughout human history, infectious diseases have been a major cause of suffering and mortality. Remarkably, it was once suggested that half of all humans who have ever lived have been killed by malaria [1]. Equally incredibly, this may represent the…
Read More
Q-POC & TB-HIRA Shortlisted
QuantuMDx are delighted to have been shortlisted in two categories in this year’s Medilink Awards. …
Read More
Diagnosing Influenza at the Point of Care
Influenza, or ‘flu’, is a common respiratory infection usually associated with a seasonal increase during…
Read More
QuantuMDx awarded Outstanding Achievement Award at Medilink Healthcare Business Awards 2024
QuantuMDx are delighted to have been awarded the Outstanding Achievement Award sponsored by Abacus at the 2024 Medilink Healthcare Business Awards. This award was for the Q-POC point of care PCR platform. It was a great evening with some truly inspiring…
Read More
World Tuberculosis Day 2024: ‘Yes! We Can End TB!’
The Role of Innovative Diagnostics Sunday 24 March 2024 is World Tuberculosis Day. March 24…
Read More
Regulatory Challenges in Molecular Diagnostics: An Overview
Working in Regulatory Affairs is never boring. We’re in a space where the ground is…
Read More
Get in touch with us
QuantuMDx Group Ltd.
Lugano Building
57 Melbourne Street
Newcastle upon Tyne
NE1 2JQ